

Connect with this vendor - Learn about this product

Canmab 440 mg Injection (Trastuzumab)

Manufacturer: Biocon

Medicine composition: Trastuzumab

Canmab 440 Mg Injection is used in the treatment of metastatic breast cancer. It works on tumors known to overexpress the protein HER2/neu. It also treats gastric cancer.

This drug is mostly administered through IV. The initial dose may be given for about 90 minutes. If the patient’s body reacts positively to Canmab 440 Mg Injection, the following doses may be given for about 30 minutes. The dosage of Canmab 440 Mg Injection that is administered generally depends on the severity of the cancer, health of the patient, body weight and height and other health problems that the patient may already have.

Ask for Quote :